BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, June 11, 2026
Home
»
Topics
» Immuno-oncology, BioWorld Science
Immuno-oncology, BioWorld Science
RSS
Campath-1H enters pivotal phase III testing stage
April 7, 1998
Prostate cancer immunotherapeutic evaluated in preclinical and clinical trials
April 6, 1998
Vaxcel acquires rights to cancer antigen
April 6, 1998
Preclinical data indicates efficacy of AltaRex's approach to cancer immunotherapy
April 2, 1998
Merck KGaA initiates worldwide cancer study with BEC2
April 2, 1998
Genentech receives fast track product designation for Herceptin
April 2, 1998
Dendreon's dendritic cell-based immunotherapy reported at AACR
March 30, 1998
Novel fusion protein with potent activity in colon cancer models reported at AACR
March 30, 1998
U.S. patent issues for Immunex's soluble CD40 ligand
March 30, 1998
Canadian notice of patent allowance for Imutec's Virulizin
March 30, 1998
Previous
1
2
…
972
973
974
975
976
977
978
979
980
…
997
998
Next
RSS